2.79
-0.01 (-0.36%)
| Penutupan Terdahulu | 2.80 |
| Buka | 2.81 |
| Jumlah Dagangan | 3,791,291 |
| Purata Dagangan (3B) | 3,100,181 |
| Modal Pasaran | 482,773,600 |
| Harga / Jualan (P/S) | 29.69 |
| Harga / Buku (P/B) | 3.87 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 May 2026 |
| Margin Operasi (TTM) | -9,653.85% |
| EPS Cair (TTM) | -0.340 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -12.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 24.34% |
| Nisbah Semasa (MRQ) | 4.93 |
| Aliran Tunai Operasi (OCF TTM) | -49.55 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -27.61 M |
| Pulangan Atas Aset (ROA TTM) | -31.37% |
| Pulangan Atas Ekuiti (ROE TTM) | -36.31% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Ovid Therapeutics Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.75 |
|
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 16.31% |
| % Dimiliki oleh Institusi | 55.97% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Ra Capital Management, L.P. | 31 Dec 2025 | 10,714,000 |
| Eventide Asset Management, Llc | 31 Dec 2025 | 4,285,000 |
| Saturn V Capital Management Lp | 31 Dec 2025 | 2,500,000 |
| Ally Bridge Group (Ny) Llc | 31 Dec 2025 | 1,785,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |